c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
DRTSW
Alpha Tau Medical Ltd. Warrant
stock
NASDAQ
Warrant
Market Open
Nov 19, 2026 10:51:14 AM EST
1.46
USD
-19.780%
(-0.36)
139,138
Pre-market
After-hours
1.3200
Bid
1.8900
Ask
0.5700
Spread
Overview
Company
Exchanges
Shorts
News
News
DRTSW News
1
/
1
Nov 19, 2026
Day breaks
Nov 15, 2026
01:00 PM EST
Alpha Tau Announces New Positive Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial: All Patients Treated are Alive with Median Survival Not Reached, 6.9 Months Median Follow-Up in the First Six Evaluable Patients With 100% ORR, 100% Feasibility and No Unanticipated Serious Adverse Events - Conference Call Scheduled for 8:30am ET November 16
·
GlobeNewswire Inc.
Nov 12, 2026
08:30 AM EST
Alpha Tau to Host Investor Call to Review New Data from the Alpha DaRT® Recurrent Glioblastoma REGAIN Trial
·
GlobeNewswire Inc.
Oct 29, 2026
12:14 PM EDT
Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange
·
GlobeNewswire Inc.
Oct 22, 2026
08:30 AM EDT
Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea
·
GlobeNewswire Inc.
Oct 19, 2026
08:30 AM EDT
Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
·
GlobeNewswire Inc.
Oct 5, 2026
09:45 AM EDT
Alpha Tau to Participate in October Investor Conferences
·
GlobeNewswire Inc.